| 1 |
27797602 | Bleomycin increases neutrophil adhesion to human vascular endothelial cells independently of upregulation of ICAM-1 and E-selectin. | 2016 Oct - Dec |
1 |
| 2 |
26209236 | Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis. | 2015 Oct |
1 |
| 3 |
23967234 | Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage. | 2013 |
2 |
| 4 |
22177985 | A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2. | 2012 Mar 1 |
1 |
| 5 |
21741938 | Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. | 2011 Sep |
1 |
| 6 |
18395486 | Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. | 2008 |
1 |
| 7 |
10229865 | Bleomycin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. | 1999 May 15 |
1 |
| 8 |
8891198 | Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease. | 1996 Jul-Aug |
1 |
| 9 |
7539030 | A role for C-C chemokines in fibrotic lung disease. | 1995 May |
2 |